About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Cleveland | 263 Studies

Clinical Trials Prostate CancerCleveland

Prostate Cancer Clinical Trials in Cleveland

Find 263 clinical trials for prostate cancer near Cleveland, Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Cleveland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 263 trials

CompletedPositioning and Tracking the Prostate During External Beam RadiationThe purpose of this study is to evaluate a non-ionizing electromagnetic method to align the prostate treatment site for radiation therapy and to monitor its position throughout…NCT00123838·Scottsdale, Arizona and 4 others CompletedToremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyAndrogen deprivation therapy (ADT) treatment for prostate cancer decreases the natural hormone called testosterone.NCT00129142·Homewood, Alabama and 154 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

WithdrawnRobotic Telesurgery in UrologyThe goal of this clinical trial is to confirm the safety and feasibility of robotic telesurgery when used for the surgical management of prostate cancer in participates undergoing…NCT07541066·Cleveland, Ohio

TerminatedGVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerThe purpose of this study is to compare the duration of survival between GVAX® immunotherapy for prostate cancer and chemotherapy treatment in patients with prostate cancer who no…NCT00089856·Alabaster, Alabama and 125 others

CompletedFor Cause Prostate Biopsy in REDUCE Population TrialThe REDUCE trial was conducted to determine whether dutasteride reduces the risk of incident prostate cancer, as detected on biopsy, among men who are at increased risk for the…NCT01529086·Cleveland, Ohio

CompletedA Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate CancerThe primary purpose of this study is to determine the safest dose of ZD4054 (Zibotentan)in men with prostate cancerNCT00055471·Cleveland, Ohio and 1 other

TerminatedJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsAvelumab in combination with talazoparib will be investigated in patients with locally advanced (primary or recurrent) or metastatic solid tumors, including non-small cell lung…NCT03330405·Fayetteville, Arkansas and 65 others

RecruitingDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseThis study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?NCT06592924·Anchorage, Alaska and 394 others

CompletedDarolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerThe purpose of the study is to assess the efficacy and safety of BAY1841788 (darolutamide (ODM-201)) in combination with standard androgen deprivation therapy (ADT) and docetaxel…NCT02799602·Chandler, Arizona and 321 others

Active not recruitingMedtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)This study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.NCT05696444·Duarte, California and 5 others

CompletedLenalidomide and GM-CSF in Treating Patients With Prostate CancerRATIONALE: Lenalidomide may stop the growth of prostate cancer by blocking blood flow to the tumor.NCT00939510·Cleveland, Ohio

CompletedApalutamide and Leuprolide in Intermediate and High-risk Prostate CancerThis is a research study to test an investigational drug (Not FDA approved), Apalutamide given in combination with Leuprolide acetate (FDA approved) in men diagnosed with…NCT02770391·Cleveland, Ohio

CompletedPilot Study Evaluating the Role of Histopathology Correlation in Treatment PlanningThis clinical research study tests the Uronav system. Patients with prostate cancer will be asked to take part in this study.NCT02681614·Cleveland, Ohio

CompletedDecision Aids to Improve Knowledge in Patients With Prostate CancerThis randomized phase III trial studies how well decision aids work in improving knowledge in patients with prostate cancer.NCT03182998·Anchorage, Alaska and 4 others

CompletedTreatment of Hemorrhagic Radiation Proctitis Using the Halo SystemThis study involves evaluating a procedure in which the study device, the HALO90 Ablation catheter, is used to heat a thin layer of tissue lining the rectum using radiofrequency…NCT01103492·Cleveland, Ohio

RecruitingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or…NCT04585750·Irvine, California and 75 others

RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45…NCT05946213·Birmingham, Alabama and 435 others

Active not recruitingA Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyThis randomized, placebo-controlled phase III trial is evaluating the benefit of rucaparib and enzalutamide combination therapy versus enzalutamide alone for the treatment of men…NCT04455750·Anchorage, Alaska and 413 others

Active not recruitingPYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate CancerThe purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the…NCT06074510·Birmingham, Alabama and 13 others

CompletedStudy of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)To test the efficacy of CP-751,871 combined with docetaxel and prednisone in the treatment of prostate cancer that is refractory to hormone therapyNCT00313781·Los Angeles, California and 17 others

PreviousPage 5 of 14Next

Other Conditions in Cleveland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma